Drug intelligence / Profile preview

USG-STAP + bupivacaine + dexmedetomidine

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Intrathecal, Perispinal (depending On Procedural Context)
01

Overview

This is a combination therapy involving ultrasound-guided stapler-assisted procedure (USG-STAP) with the co-administration of bupivacaine and dexmedetomidine. - **USG-STAP** refers to an interventional technique performed under ultrasound guidance, though the specific "STAP" acronym is not standard in medical literature and may refer to a particular surgical or procedural approach using a stapler device under sonographic visualization[4]. - **Bupivacaine** is a long-acting local anesthetic that blocks sodium channels, inhibiting nerve impulse transmission and providing regional anesthesia or analgesia. - **Dexmedetomidine** is an alpha-2 adrenergic receptor agonist used as an adjuvant to prolong sensory and motor block duration when combined with local anesthetics like bupivacaine[6][8][10]. It provides sedative, anxiolytic, and analgesic effects without significant respiratory depression. The combination of these agents in procedures such as spinal or regional anesthesia has been shown to enhance postoperative analgesia by prolonging sensory block duration and reducing opioid requirements[6][8][10].

Other names
USG-STAP + bupivacaine + dexmedetomidine
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)ADRA2A (α2A)

Beyond the preview

Go deeper on USG-STAP + bupivacaine + dexmedetomidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on USG-STAP + bupivacaine + dexmedetomidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call